Plasticity of immune system vs. memory therapy IST.
Pharmacotherapy and immunotherapy are the main treatments for allergic diseases to inhalants. This study investigates whether to repeat short cycles of immunotherapy after 3 or 5 years the from interruption of the first therapeutic cycle, lasting 3-4 years, to maintain immune memory in individuals subjected to IST. We have compared two groups, one of 452 patients who, after the first treatment for 3-4 years of IST, performed a cycle of four months after three and 10 years from the suspension, and a second group of 126 individuals who have performed only the IST treatment for 3-4 years. The best results were obtained in the first group. These results are due to the immune system's plasticity, a very important concept in clinical practice.